The influence of down-regulation of focal adhesion kinase by RNA interference on the adhesion and migration of rat hepatic stellate cells in vitro.
- Author:
Jun-yan AN
1
;
Xiao-lan ZHANG
;
Dong-mei YAO
;
Zhi-na DUN
;
Shu-rui XIE
;
Li-sen HAO
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Blotting, Western; Cell Adhesion; Cell Line; Cell Movement; Down-Regulation; Fibronectins; Focal Adhesion Kinase 1; genetics; metabolism; Genetic Vectors; Hepatic Stellate Cells; cytology; enzymology; Liver Cirrhosis; pathology; prevention & control; Plasmids; genetics; Polymerase Chain Reaction; RNA Interference; RNA, Messenger; genetics; metabolism; Rats; Transfection
- From: Chinese Journal of Hepatology 2009;17(7):509-514
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the role of focal adhesion kinase (FAK) in adhesion and migration of hepatic stellate cells (HSC).
METHODSTwo recombinant plasmids expressing short hairpin RNAs (shRNAs) targeting FAK were constructed and one plasmid substantially suppressing FAK expression in HSC was selected. Real-time PCR and Western blot were used to detect the knockdown effects of FAK gene. After 48-hour treatment with FAK shRNA, toluidine blue colorimetric assay was used to detect the cell adhesion. Wound-healing assay and improved Boyden double-chamber were used to detect the cell migration induced by FN.
RESULTSThe recombinant plasmid expressing FAK shRNA was successfully constructed and transfected into HSC. Compared with the controls, the expression of FAK mRNA and protein in HSC treated with FAK shRNA was markedly down-regulated by 76.82% and 72.53%, respectively. The expression of p-FAK (Tyr397) protein was also decreased by 62.71% 48 h posttransfection. The adhesion of HSC was inhibited by 58.69% at 48 h after shRNA transfection. FAK gene silencing could also dramatically inhibit FN-stimulated HSC migration, and the cell migration distance and the cell number of crossing membrane were decreased by 58.27% and 83.70%, respectively.
CONCLUSIONSFAK gene silencing suppresses adhesion and migration of HSC, and FAK may be a potential target for novel anti-fibrosis therapies.